BOSTON SCIENTIFIC CORPORATION Goodwill, Translation and Purchase Accounting Adjustments
BOSTON SCIENTIFIC CORPORATION (BSX) reported Goodwill, Translation and Purchase Accounting Adjustments of -$20.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for the quarter ending 2026-06-30 was -$1.00M, a 101.15% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for the quarter ending 2026-03-31 was -$19.00M, a 140.43% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for the quarter ending 2025-12-31 was $17.00M.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for the quarter ending 2025-09-30 was -$17.00M, a 123.29% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for fiscal 2025 was $134.00M.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for fiscal 2024 was -$86.00M, a 530.00% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for fiscal 2023 was $20.00M.
- BOSTON SCIENTIFIC CORPORATION goodwill, translation and purchase accounting adjustments for fiscal 2022 was -$98.00M.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 3 month | Goodwill, Translation and Purchase Accounting Adjustments 6 month | Goodwill, Translation and Purchase Accounting Adjustments 9 month | Goodwill, Translation and Purchase Accounting Adjustments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$20.00M 10-Q · filed 2026-08-03 | -$3.00M derived: sum of 3 quarters · filed 2026-08-03 | -$20.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$19.00M 10-Q · filed 2026-05-01 | -$2.00M derived: sum of 2 quarters · filed 2026-05-01 | -$19.00M derived: sum of 3 quarters · filed 2026-05-01 | $68.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $87.00M derived: sum of 3 quarters · filed 2026-02-17 | $134.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | -$17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $70.00M derived: sum of 2 quarters · filed 2025-11-03 | $117.00M 10-Q · filed 2025-11-03 | $19.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-06-30 | $87.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $134.00M 10-Q · filed 2025-08-01 | $36.00M derived: sum of 3 quarters · filed 2026-02-17 | $109.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-03-31 | $47.00M 10-Q · filed 2025-05-01 | -$51.00M derived: sum of 2 quarters · filed 2026-02-17 | $22.00M derived: sum of 3 quarters · filed 2026-02-17 | $12.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | -$98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$25.00M derived: sum of 2 quarters · filed 2026-02-17 | -$35.00M derived: sum of 3 quarters · filed 2026-02-17 | -$86.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $63.00M derived: sum of 2 quarters · filed 2024-11-01 | $12.00M 10-Q · filed 2024-11-01 | $61.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$61.00M 10-Q · filed 2024-08-01 | -$12.00M derived: sum of 3 quarters · filed 2025-02-18 | -$66.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | -$51.00M 10-Q · filed 2024-05-01 | -$2.00M derived: sum of 2 quarters · filed 2025-02-18 | -$56.00M derived: sum of 3 quarters · filed 2025-02-18 | -$44.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$5.00M derived: sum of 2 quarters · filed 2025-02-18 | $7.00M derived: sum of 3 quarters · filed 2025-02-18 | $20.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$42.00M derived: sum of 2 quarters · filed 2023-11-01 | -$29.00M 10-Q · filed 2023-11-01 | $39.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2023-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $25.00M 10-Q · filed 2023-08-03 | $93.00M derived: sum of 3 quarters · filed 2024-02-20 | $20.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2023-03-31 | $13.00M 10-Q · filed 2023-05-04 | $81.00M derived: sum of 2 quarters · filed 2024-02-20 | $8.00M derived: sum of 3 quarters · filed 2024-02-20 | -$58.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$5.00M derived: sum of 2 quarters · filed 2024-02-20 | -$71.00M derived: sum of 3 quarters · filed 2024-02-20 | -$98.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | -$73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$139.00M derived: sum of 2 quarters · filed 2022-11-03 | -$166.00M 10-Q · filed 2022-11-03 | -$173.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-06-30 | -$66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$93.00M 10-Q · filed 2022-08-04 | -$100.00M derived: sum of 3 quarters · filed 2023-02-23 | -$118.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-03-31 | -$27.00M 10-Q · filed 2022-05-05 | -$34.00M derived: sum of 2 quarters · filed 2023-02-23 | -$52.00M derived: sum of 3 quarters · filed 2023-02-23 | -$48.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$25.00M derived: sum of 2 quarters · filed 2023-02-23 | -$21.00M derived: sum of 3 quarters · filed 2023-02-23 | -$27.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$14.00M derived: sum of 2 quarters · filed 2021-11-04 | -$20.00M 10-Q · filed 2021-11-04 | $41.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2021-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.00M 10-Q · filed 2021-08-06 | $59.00M derived: sum of 3 quarters · filed 2022-02-23 | $95.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2021-03-31 | -$6.00M 10-Q · filed 2021-05-06 | $55.00M derived: sum of 2 quarters · filed 2022-02-23 | $91.00M derived: sum of 3 quarters · filed 2022-02-23 | $94.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $97.00M derived: sum of 2 quarters · filed 2022-02-23 | $100.00M derived: sum of 3 quarters · filed 2022-02-23 | $22.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $39.00M derived: sum of 2 quarters · filed 2020-11-05 | -$39.00M 10-Q · filed 2020-11-05 | $28.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$75.00M 10-Q · filed 2020-08-05 | -$8.00M derived: sum of 3 quarters · filed 2021-02-23 | -$10.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | -$78.00M 10-Q · filed 2020-05-06 | -$11.00M derived: sum of 2 quarters · filed 2021-02-23 | -$13.00M derived: sum of 3 quarters · filed 2021-02-23 | -$10.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $65.00M derived: sum of 2 quarters · filed 2021-02-23 | $68.00M derived: sum of 3 quarters · filed 2021-02-23 | $66.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.00M derived: sum of 2 quarters · filed 2019-11-05 | -$1.00M 10-Q · filed 2019-11-05 | -$1.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $1.00M 10-Q · filed 2019-07-30 | $1.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | -$2.00M 10-Q · filed 2019-04-29 | -$2.00M derived: sum of 2 quarters · filed 2020-02-25 | -$2.00M derived: sum of 3 quarters · filed 2020-02-25 | -$14.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | -$12.00M derived: sum of 3 quarters · filed 2020-02-25 | -$29.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | -$12.00M derived: sum of 2 quarters · filed 2018-10-29 | -$29.00M 10-Q · filed 2018-10-29 | -$30.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2018-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$29.00M 10-Q · filed 2018-07-31 | -$30.00M derived: sum of 3 quarters · filed 2019-02-19 | -$25.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2018-03-31 | -$17.00M 10-Q · filed 2018-05-01 | -$18.00M derived: sum of 2 quarters · filed 2019-02-19 | -$13.00M derived: sum of 3 quarters · filed 2019-02-19 | -$7.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $4.00M derived: sum of 2 quarters · filed 2019-02-19 | $10.00M derived: sum of 3 quarters · filed 2019-02-19 | $12.00M 10-K · filed 2019-02-19 |
| 2017-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $11.00M derived: sum of 2 quarters · filed 2017-11-02 | $13.00M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.00M 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $2.00M 10-Q · filed 2017-05-03 | |||
| 2016-12-31 | -$3.00M 10-K · filed 2018-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |